-
MHRA clarifies UK route for microbiome medicines
Read the full story: MHRA clarifies UK route for microbiome medicinesUK regulators have clarified the licensing route for microbiome medicines. The MHRA says emerging therapies can use existing medicines frameworks, while developers must address manufacturing consistency, safety, antimicrobial-resistance risks, and robust clinical evidence.
Latest stories —
-
The Tesla Factor: Leading Organisations Through Uncertainty and Change
Adaptive leadership has emerged as the ultimate tool for steering…
-
Utilising Analytics for Marketing Campaign Success
From personalised recommendations to real-time campaign adjustments, data-driven marketing has…
Read the latest edition of Business Quarter:
Leadership —
-
Cypher Capital appoints Saidi to lead multi-asset expansion
Cypher Capital has appointed Arash Saidi chief executive officer today. The investment manager is broadening its strategy across digital assets, AI infrastructure, and technology-focused private equity.
